99455-06-8

Basic information

• Product Name: 5-BROMO-2-METHOXYQUINOLINE
• Synonyms: 5-BROMO-2-METHOXYQUINOLINE
• CAS NO: 99455-06-8
• Molecular Formula: C10H8BrNO
• Molecular Weight: 238.083
• Mol File: 99455-06-8.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-BROMO-2-METHOXYQUINOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-2-METHOXYQUINOLINE(99455-06-8)
• EPA Substance Registry System: 5-BROMO-2-METHOXYQUINOLINE(99455-06-8)

Safety Data

• Hazardous Substances Data: 99455-06-8(Hazardous Substances Data)

Usage

General Description

5-BROMO-2-METHOXYQUINOLINE is a chemical compound with the molecular formula C10H8BrNO. It is a quinoline derivative that contains a bromine atom and a methoxy group attached to the quinoline ring. 5-BROMO-2-METHOXYQUINOLINE is commonly used in chemical synthesis and pharmaceutical research as a building block for the preparation of various bioactive molecules. It has also been studied for its potential antimalarial and antimicrobial properties. 5-BROMO-2-METHOXYQUINOLINE may be considered a useful tool in drug discovery and development due to its unique structural and chemical properties. However, its exact biological and pharmacological activities are still being investigated.

Upstream product

• 124-41-4 sodium methylate 
• 99455-13-7 5-bromo-2-chloroquinoline 
• 99465-09-5 5-bromoquinolin-2(1H)-one 
• 99465-18-6 (E)-N-(3-bromophenyl)-3-ethoxypropenamide 
• 591-19-5 m-Bromoaniline 
• 67-56-1 methanol 
• 846038-45-7 5-bromoquinoline N-oxide 

Relevant articles and documents

Enantioselective Copper-Catalyzed Alkynylation of Benzylic C-H Bonds via Radical Relay

The first enantioselective alkynylation of benzylic C-H bonds via copper-catalyzed radical relay has been established herein, which provides an easy access to structurally diverse benzylic alkynes in good yields with excellent enantioselectivities. A key step for the asymmetric copper-catalyzed radical relay process is the enantioselective capture of a benzylic radical with chiral (Box)CuII-alkynyl species. In addition, the reaction displays good functional group tolerance, broad substrate scope, and mild conditions. The enantioenriched alkynylation products can be readily transformed into highly valuable synthons, such as chiral terminal alkynes, allenes, alkenes, and carboxylic acids. More importantly, our methodology can be applied to the synthesis of bioactive molecule AMG 837.

GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE

Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.